Our growing understanding of the many types and functions of RNA has been combined with the ability to synthesize modified RNAs with improved stability and pharmaceutical activity. Nanotechnology-based systems to deliver those RNAs to the cell have resulted in an explosion of new therapeutic options for diseases ranging from viral infections to cancer. This arsenal of multiple specifically targeted RNA therapies has the potential to revolutionize the treatment of human disease.